Vonoprazan non‐inferior to lansoprazole in treating duodenal ulcer and eradicating <scp><i>Helicobacter pylori</i></scp> in Asian patients

Hou, Xiaohua; Meng, Fandong; Wang, Jiangbin; Sha, Weihong; Chiu, Cheng‐Tang; Chul Chung, Woo; Gu, Liqun; Kudou, Kentarou; Fung Chong, Chui; Zhang, Shutian

doi:10.1111/jgh.15837

Public

Vonoprazan non‐inferior to lansoprazole in treating duodenal ulcer and eradicating Helicobacter pylori in Asian patients

Published in Journal of Gastroenterology and Hepatology • Mar 28, 2022

Authors:

Xiaohua Hou

Fandong Meng

Jiangbin Wang

Abstract

BACKGROUND AND AIM: Duodenal ulcers, especially caused by increasingly drug-resistant Helicobacter pylori, are a concern in Asia. We compared oral vonoprazan versus lansoprazole for efficacy (healing duodenal ulcers) and safety in non-Japanese Asian patients. METHODS: In this phase 3, randomized (1:...

Subject

Lansoprazole

Medicine

Helicobacter pylori

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!